News

Labiotech.eu2d
The emergence of BTK inhibitors in multiple sclerosis treatment: Companies close in on approval
Discover why BTK inhibitors have attracted interest for treating multiple sclerosis, as a few late-stage candidates close in ...
SWI swissinfo.ch2d
Novartis and Sanofi call for higher drug prices in Europe
Swiss and French pharmaceutical companies Novartis and Sanofi argue that the EU should adjust its drug prices to better align with those in the US.
Cyprus Mail2d
Is President Trump willing to break the Swiss golden egg?
Top Swiss officials will this week test whether big commitments to the U.S. can help secure relief from import tariffs, after ...
Switzerland flexes financial muscle ahead of tariff date in Washington
Top Swiss officials will this week test whether big commitments to the U.S. can help secure relief from import tariffs, after ...
The Cool Down3d
Researchers pioneer breakthrough that could change how medicine is made: 'These ... drive desired reactions forward'
Researchers at the University of Missouri have developed a chemical tool that uses "soapy" water and electricity to ...
Stockhead3d
Big pharma Sandoz steps into Aussie CBD scene; could this be the start of a rush?
Big pharma’s jumped into CBD sleep land with Sandoz backing Avecho; could this bring a new rush into ASX CBD stocks like Neurotech?
SWI swissinfo.ch3d
Swiss pharma giant Roche to invest $50bn in US within five years
After Novartis, fellow Swiss pharmaceutical company Roche plans to invest up to $50 billion in the US over the next five ...
Precision Medicine Online6d
Machine Learning-Based Blood Test Shows Promise in Predicting CAR T-Cell Therapy Response
The tool analyzes results from standard tests of organ function, tumor burden, and inflammation to predict whether lymphoma patients will respond to treatment.